Merck KGaA (OTCMKTS:MKGAF) Trading Up 4.7% – Here’s Why
by Tristan Rich · The Markets DailyMerck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price was up 4.7% during trading on Monday . The company traded as high as $143.1810 and last traded at $143.1810. Approximately 310 shares traded hands during mid-day trading, a decline of 64% from the average daily volume of 869 shares. The stock had previously closed at $136.74.
Merck KGaA Stock Performance
The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $17.84 billion, a price-to-earnings ratio of 21.07 and a beta of 0.96. The stock’s 50-day simple moving average is $135.43 and its 200 day simple moving average is $132.28.
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
- Five stocks we like better than Merck KGaA
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Is Nutanix the Best Comeback Trade Left in 2025? The Setup Says Yes
- Airline Stocks – Top Airline Stocks to Buy Now
- The Vertiv Pullback: Ignore the Noise, Buy the Data
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Insiders Buy Natural Gas Stocks: 2 for the Watchlist